HealthEquity Inc. (HQY)
HealthEquity Statistics
Share Statistics
HealthEquity has 86.5M shares outstanding. The number of shares has increased by -0.59% in one year.
| Shares Outstanding | 86.5M |
| Shares Change (YoY) | -0.59% |
| Shares Change (QoQ) | -0.19% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 84.08M |
| Failed to Deliver (FTD) Shares | 10 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 6.18M, so 7.14% of the outstanding shares have been sold short.
| Short Interest | 6.18M |
| Short % of Shares Out | 7.14% |
| Short % of Float | 8.35% |
| Short Ratio (days to cover) | 4.86 |
Valuation Ratios
The PE ratio is 99.19 and the forward PE ratio is 23.66. HealthEquity's PEG ratio is 1.4.
| PE Ratio | 99.19 |
| Forward PE | 23.66 |
| PS Ratio | 7.99 |
| Forward PS | 4.8 |
| PB Ratio | 4.54 |
| P/FCF Ratio | 28.4 |
| PEG Ratio | 1.4 |
Enterprise Valuation
HealthEquity has an Enterprise Value (EV) of 10.4B.
| EV / Sales | 8.67 |
| EV / EBITDA | 30.82 |
| EV / EBIT | 30.62 |
| EV / FCF | 30.8 |
Financial Position
The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.52.
| Current Ratio | 3.06 |
| Quick Ratio | 3.06 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 3.28 |
| Debt / FCF | 3.28 |
| Interest Coverage | 2.68 |
Financial Efficiency
Return on Equity is 4.57% and Return on Invested Capital is 4.1%.
| Return on Equity | 4.57% |
| Return on Assets | 2.8% |
| Return on Invested Capital | 4.1% |
| Revenue Per Employee | $386.4K |
| Profits Per Employee | $31.14K |
| Employee Count | 3,105 |
| Asset Turnover | 0.35 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 19.33M |
| Effective Tax Rate | 16.66% |
Stock Price Statistics
The stock price has increased by 10.65% in the last 52 weeks. The beta is 0.49, so HealthEquity's price volatility has been higher than the market average.
| Beta | 0.49 |
| 52-Week Price Change | 10.65% |
| 50-Day Moving Average | 91.59 |
| 200-Day Moving Average | 90.42 |
| Relative Strength Index (RSI) | 52.76 |
| Average Volume (20 Days) | 1.09M |
Income Statement
In the last 12 months, HealthEquity had revenue of 1.2B and earned 96.7M in profits. Earnings per share was 1.11.
| Revenue | 1.2B |
| Gross Profit | 777.26M |
| Operating Income | 162.33M |
| Net Income | 96.7M |
| EBITDA | 337.54M |
| EBIT | 176.67M |
| Earnings Per Share (EPS) | 1.11 |
Balance Sheet
The company has 295.95M in cash and 1.11B in debt, giving a net cash position of -812.57M.
| Cash & Cash Equivalents | 295.95M |
| Total Debt | 1.11B |
| Net Cash | -812.57M |
| Retained Earnings | 0 |
| Total Assets | 3.45B |
| Working Capital | 321.43M |
Cash Flow
In the last 12 months, operating cash flow was 339.86M and capital expenditures -2.08M, giving a free cash flow of 337.77M.
| Operating Cash Flow | 339.86M |
| Capital Expenditures | -2.08M |
| Free Cash Flow | 337.77M |
| FCF Per Share | 3.89 |
Margins
Gross margin is 64.78%, with operating and profit margins of 13.53% and 8.06%.
| Gross Margin | 64.78% |
| Operating Margin | 13.53% |
| Pretax Margin | 9.67% |
| Profit Margin | 8.06% |
| EBITDA Margin | 28.13% |
| EBIT Margin | 13.53% |
| FCF Margin | 28.15% |
Dividends & Yields
HQY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.01% |
| FCF Yield | 3.52% |
Analyst Forecast
The average price target for HQY is $109.5, which is 24.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $109.5 |
| Price Target Difference | 24.1% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
Scores
| Altman Z-Score | 4 |
| Piotroski F-Score | 6 |